Loading clinical trials...
Loading clinical trials...
Investigators use clinical data from a large sample of COVID-19 disease patients to screen out biomarkers associated with disease severity. Then, a novel nomogram model will be established to predict ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Xinqiao Hospital of Chongqing
NCT04417257 · COVID-19 Disease
NCT04830800 · COVID-19 Disease, SARS Pneumonia, and more
NCT06701747 · Massive Transfusion, Nomogram Model
NCT04482699 · Severe COVID-19 Disease
NCT04542967 · Severe COVID-19 Disease
Xinqiao Hospital of Chongqing
Chongqing, Chongqing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions